Recent progress on liver kinase B1 (LKB1): Expression, regulation, downstream signaling and cancer suppressive function

66Citations
Citations of this article
95Readers
Mendeley users who have this article in their library.

Abstract

Liver kinase B1 (LKB1), known as a serine/threonine kinase, has been identified as a critical cancer suppressor in many cancer cells. It is a master upstream kinase of 13 AMP-activated protein kinase (AMPK)-related protein kinases, and possesses versatile biological functions. LKB1 gene is mutated in many cancers, and its protein can form different protein complexes with different cellular localizations in various cell types. The expression of LKB1 can be regulated through epigenetic modification, transcriptional regulation and post-translational modification. LKB1 dowcnstream pathways mainly include AMPK, microtubule affinity regulating kinase (MARK), salt-inducible kinase (SIK), sucrose non-fermenting protein-related kinase (SNRK) and brain selective kinase (BRSK) signalings, etc. This review, therefore, mainly discusses recent studies about the expression, regulation, downstream signaling and cancer suppressive function of LKB1, which can be helpful for better understanding of this molecular and its significance in cancers.

Author supplied keywords

Cite

CITATION STYLE

APA

Gan, R. Y., & Li, H. B. (2014, September 19). Recent progress on liver kinase B1 (LKB1): Expression, regulation, downstream signaling and cancer suppressive function. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms150916698

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free